About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Voyager PAD Trial: How Effective Is Rivaroxaban for Patients with Lower Extremity PAD Undergoing Revascularization?
By
American College of Cardiology
FEATURING
Peter Block
,
Deepak Bhatt
By
American College of Cardiology
FEATURING
Peter Block
,
Deepak Bhatt
1,854 views
October 22, 2020
2 Comments
Login to view comments.
Click here to Login
Featured Video
06:09
Penumbra, Inc.
Safety and Efficacy of Coronary Penumbra Device in ST elevation Myoc…
Feat.
A. Gupta
Featured Video
06:09
Penumbra, Inc.
Safety and Efficacy of Coronary Penumbra Device in ST elevation Myoc…
Feat.
A. Gupta
Related Content
AUTOPLAY
ON
Medical College of Georgia - Augusta University
Cardiovascular Summit at Kiawah 2024
Thu, Jul 18, 2024
14:39
Lankenau
Management of AF patients with ACS
Feat.
P. Kowey,
D. Ice
15:40
ACC 2022 Conference Coverage
ACC 2022: Triple Therapy - When to Use and How Long
Feat.
D. Kumbhani
12:18
CCM® Therapy
HRS 2024: Cardiac Contractility Modulation - Don’t Wait!
Feat.
R. Kahwash
57:30
McMaster University Department of Medicine
Five Things Every Internist Should Know About Anticoagulants
Feat.
S. Mithoowani
13:58
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
Feat.
J. Thomas Heywood
40:17
American College of Cardiology
Heart Failure with Preserved Ejection Fraction: Current Perspectives…
Feat.
S. Shah
06:23
CVRx | Barostim
ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…
Feat.
W. Abraham,
F. Arribas,
M. Zile
06:16
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT
Feat.
D. Yaranov
11:49
CVRx | Barostim
ESC 2023: Unmet needs and opportunities with device therapies of HFr…
Feat.
W. Abraham
12:21
CVRx | Barostim
Baroreflex Activation Therapy Overview of Clinical Data
Feat.
L. Tsao
28:03
Houston Methodist DeBakey Heart and Vascular Center
How to Detect and Treat Heart Failure with Preserved Ejection Fracti…
31:10
Insights from 2024 ACP Annual Meeting
ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …
Feat.
D. Berg
16:11
Jeffrey Weitz
Extended Anticoagulation for VTE
14:18
CCM® Therapy
The CCM Solution: How Does it Work and What Does it Do?
Feat.
N. Varma
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …
Feat.
M. Kittleson
19:30
American Heart & Vascular Institute
ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…
Feat.
B. Reddy
24:19
Ajith Nair
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy
Feat.
A. Nair
21:51
Cedars Sinai
Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…
Feat.
W. Boden
09:54
Mount Sinai
The ISCHEMIA Trial: Are There Differences in Primary and Secondary O…
Feat.
G. Stone
54:29
Terumo Interventional Systems
Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evalua…
Feat.
J. Spertus
